Severe cardiac toxicity due to halofantrine: Importance of underlying heart disease

Journal of Travel Medicine

Volumn 9, Issue 4, 2002, Pages 214-215

  Olivier, Bouchaud ^a,b   Fabrice, Bruneel ^a   Ricarda, Schiemann ^a   Gilles, Peytavin ^a   Coulaud, Jean P ^a  

^a BICHAT HOSPITAL   (France)

^b AVICENNE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HALOFANTRINE; ANTIMALARIAL AGENT; PHENANTHRENE DERIVATIVE;

ADULT; AGED; ARTICLE; CARDIOTOXICITY; CASE REPORT; CHEMOPROPHYLAXIS; CLINICAL EXAMINATION; CLINICAL FEATURE; DRUG SAFETY; ELECTROCARDIOGRAM; FEMALE; HUMAN; LONG QT SYNDROME; MALARIA; PLASMODIUM FALCIPARUM; RISK ASSESSMENT; CHEMICALLY INDUCED DISORDER; FATALITY; HEART ARREST; HEART DISEASE; MALARIA FALCIPARUM;

ADULT; AGED; ANTIMALARIALS; FATAL OUTCOME; FEMALE; HEART ARREST; HEART DISEASES; HUMANS; MALARIA, FALCIPARUM; PHENANTHRENES;

EID: 0036638018     PISSN: 11951982     EISSN: None     Source Type: Journal    
DOI: 10.2310/7060.2002.24026     Document Type: Article

References (12)

1. Halofantrine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic potential
2. Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria
3. Drug alert: Halofantrine. Change in recommendations for use
4. Halofantrine given with food for falciparum malaria
5. Sudden deaths while on halofantrine treatment. A report of two cases from Peshawar
6. Halofantrine-associated ventricular fibrillation in a young woman with no predisposing QTc prolongation
7. Mechanism of cardiotoxicity of halofantrine
8. Clinical efficacy and pharmacokinetics of micronized halofantrine for the treatment of acute uncomplicated falciparum malaria in nonimmune patients
9. Cardiac effects of standard-dose halofantrine therapy
10. Electrocardiographic changes and halofantrine plasma level during acute falciparum malaria
11. Surdosage à l'halofantrine
12. QT prolongation and ventricular arrhythmias